Syneos Health, Inc.

JPMORGAN CHASE & CO

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

554,483

Value ($000)

23,366

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	23,366	0.0%	554,483	6/30/2023
2023 Q1	5/18/2023	81,640	0.0%	2,291,984	3/31/2023
2022 Q4	2/13/2023	80,063	0.0%	2,182,741	12/31/2022
2022 Q3	11/14/2022	103,756	0.0%	2,200,519	9/30/2022
2022 Q2	8/11/2022	156,251	0.0%	2,179,864	6/30/2022
2022 Q1	5/11/2022	181,147	0.0%	2,237,768	3/31/2022
2021 Q4	2/11/2022	228,351	0.0%	2,223,913	12/31/2021
2021 Q3	11/12/2021	210,276	0.0%	2,403,697	9/30/2021
2021 Q2	8/12/2021	223,840	0.0%	2,501,291	6/30/2021
2021 Q1	5/12/2021	191,178	0.0%	2,520,468	3/31/2021
2020 Q4	2/19/2021	173,386	0.0%	2,544,930	12/31/2020
2020 Q3	11/12/2020	121,300	0.0%	2,289,990	9/30/2020
2020 Q2	8/11/2020	115,827	0.0%	1,988,440	6/30/2020
2020 Q1	5/12/2020	73,409	0.0%	1,862,229	3/31/2020
2019 Q4	2/11/2020	105,459	0.0%	1,773,174	12/31/2019